Skip to main content

and
  1. Article

    Open Access

    Development and application of a weighted change score to evaluate interventions for vasomotor symptoms in patients with breast cancer using regression trees: a cohort study

    Vasomotor symptoms (VMS) are common among individuals with breast cancer (BC) and poorly managed symptoms are associated with reduced quality of life, treatment discontinuation, and poorer breast cancer outcom...

    Katherine Marie Cole, Sharon McGee, Mark Clemons in Breast Cancer Research and Treatment (2024)

  2. No Access

    Article

    The COVID-19 pandemic and its effects on follow-up of patients with early breast cancer: A patient survey

    Despite limited evidence supporting its effectiveness, most guidelines recommend long-term, routinely scheduled in-person surveillance of patients with early breast cancer (EBC). The COVID-19 pandemic led to i...

    Ana-Alicia Beltran-Bless, Gail Larocque in Breast Cancer Research and Treatment (2024)

  3. Article

    Open Access

    Increasing palliative care capacity in primary care: study protocol of a cluster randomized controlled trial of the CAPACITI training program

    Primary care providers play a critical role in providing early palliative care to their patients. Despite the availability of clinical education on best practices in palliative care, primary care providers oft...

    Hsien Seow, Daryl Bainbridge, Samantha Winemaker, Kelli Stajduhar in BMC Palliative Care (2023)

  4. Article

    Open Access

    Artichoke phytocomplex modulates serum microRNAs in patients exposed to asbestos: a first step of a phase II clinical trial

    Malignant pleural mesothelioma is a highly aggressive tumor associated with asbestos exposure. There are few effective treatment options for mesothelioma, and patients have a very poor prognosis. Mesothelioma ...

    Paola Muti, Andrea Sacconi, Claudio Pulito in Journal of Experimental & Clinical Cancer … (2022)

  5. No Access

    Article

    Symptomatic skeletal-related events in patients receiving longer term bone-modifying agents for bone metastases from breast and castration resistant prostate cancers

    The effect of longer-term use of bone-modifying agent (BMA) on symptomatic skeletal event (SSE) rates in patients with bone metastases remains unclear. This retrospective study of a cohort of patients in a ran...

    Mashari Alzahrani, Carol Stober, Michelle Liu, Arif Awan in Supportive Care in Cancer (2022)

  6. Article

    Perceptions around bone-modifying agent use in patients with bone metastases from breast and castration resistant prostate cancer: a patient survey

    Optimal use of bone-modifying agent (BMA) therapy in patients with bone metastases from breast and castrate-resistant prostate cancer (CRPC) is evolving.

    Mashari Alzahrani, Mark Clemons, Marta Sienkiewicz in Supportive Care in Cancer (2021)

  7. No Access

    Article

    Extent of Surgical Resection in Inflammatory Bowel Disease Associated Colorectal Cancer: a Population-Based Study

    The extent of surgical resection in inflammatory bowel disease (IBD) patients who develop colorectal cancer (CRC) is not prescribed by guidelines. We aim to evaluate, at a population level, the association of ...

    Jessica Bogach, Gregory Pond, Cagla Eskicioglu in Journal of Gastrointestinal Surgery (2021)

  8. Article

    Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey

    Despite the increasing use of adjuvant bone-modifying agents (BMAs) such as zoledronate and clodronate in the treatment of patients with early stage breast cancer (EBC), little is known about real world practi...

    Sharon McGee, Mashari Alzahrani, Lisa Vandermeer in Breast Cancer Research and Treatment (2021)

  9. No Access

    Article

    Assessment of spring water quality in Jhimruk River Watershed, Lesser Himalaya, Nepal

    Springs are primary water sources for drinking and sanitation in rural households of mountainous areas and are ecologically important as they provide habitat to diverse macroinvertebrate assemblages. This stud...

    Bhumika Thapa, Ramesh Raj Pant, Sudeep Thakuri in Environmental Earth Sciences (2020)

  10. No Access

    Article

    A prospective intervention to improve happiness and reduce burnout in oncologists

    There is a paucity of data about effective interventions to improve happiness and reduce burnout in oncologists. Benjamin Franklin developed a 13-week program of “necessary activities” or “virtues” (temperance...

    Mark Clemons, Sasha Mazzarello, Gregory Pond, Eitan Amir in Supportive Care in Cancer (2019)

  11. No Access

    Article

    A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer

    Some women report cognitive impairment after adjuvant chemotherapy (CTh) for breast cancer. Here we explore cognitive function, and underlying mechanisms with blood tests and functional magnetic resonance imag...

    Janette L. Vardy, Myrle M. Stouten-Kemperman, Gregory Pond in Brain Imaging and Behavior (2019)

  12. Article

    Open Access

    Validation of a modified VOICES survey to measure end-of-life care quality: the CaregiverVoice survey

    Measuring the care experience at end-of-life (EOL) to inform quality improvement is a priority in many countries. We validated the CaregiverVoice survey, a modified version of the VOICES questionnaire, complet...

    Hsien Seow, Daryl Bainbridge, Melissa Brouwers, Gregory Pond in BMC Palliative Care (2017)

  13. No Access

    Article

    Assessment of function and quality of life in a phase II multi-institutional clinical trial of fractionated simultaneous in-field boost radiotherapy for patients with 1–3 metastases

    We examined functional outcomes and quality of life of whole brain radiotherapy (WBRT) with integrated fractionated stereotactic radiotherapy boost (FSRT) for brain metastases treatment. Eighty seven people w...

    Glenn Bauman, Slav Yartsev, David Roberge, Robert MacRae in Journal of Neuro-Oncology (2016)

  14. No Access

    Article

    A phase II study of cediranib, an oral VEGF inhibitor, in previously untreated patients with metastatic or recurrent malignant melanoma

    Purpose A two stage multi-institution Phase II study was undertaken by the Princess Margaret Hospital Consortium to evaluate the efficacy and toxicity of oral cediranib, an inhibitor of v...

    Elaine McWhirter, Ian Quirt, Thomas Gajewski, Gregory Pond in Investigational New Drugs (2016)

  15. Article

    Open Access

    A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events

    The optimal frequency of intravenous (IV) bisphosphonate administration is unclear. We thus performed a study evaluating the effects of switching from 3–4 to 12 weekly therapy in patients with biochemically d...

    Christina L. Addison, Nathaniel Bouganim in Breast Cancer Research and Treatment (2014)

  16. Article

    Open Access

    A target based approach identifies genomic predictors of breast cancer patient response to chemotherapy

    The efficacy of chemotherapy regimens in breast cancer patients is variable and unpredictable. Whether individual patients either achieve long-term remission or suffer recurrence after therapy may be dictated ...

    Robin M Hallett, Gregory Pond, John A Hassell in BMC Medical Genomics (2012)

  17. No Access

    Article

    The use and toxicity of steroids in the management of patients with brain metastases

    To document the use of steroids and frequency of their side effects in patients with brain metastases.

    Alina Sturdza, Barbara-Ann Millar, Neelufer Bana in Supportive Care in Cancer (2008)

  18. No Access

    Article

    Sucralfate mouthwash for prevention and treatment of 5-fluorouracil-induced mucositis: a randomized, placebo-controlled trial

    A randomized, double-blind, placebo-controlled trial was conducted to evaluate the effectiveness of a sucralfate mouthwash in preventing and alleviating oral mucositis induced by 5-fluorouracil (5FU). A total...

    Michelle Nottage, Sue-Anne McLachlan, Mary-Anne Brittain in Supportive Care in Cancer (2003)